Home > Insider Trading > Filing (0000882104-20-000187)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
882104	Pdl Biopharma Inc.	PDLI	Biological Products, (No Disgnostic Substances) (2836)	943023969

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1296974	Lee Alan Bazaar	932 Southwood Blvd. Incline Village NV 89451		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-11-18	37,080	$1.71	70,515	No	4	M	Direct
Common Stock	Disposition	2020-11-18	26,642	$2.38	43,873	No	4	F	Direct
Common Stock	Disposition	2020-11-20	33,435	$2.42	10,438	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-11-18	37,080	$1.71	37,080	$1.71

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2021-04-17	2030-04-17	No	4	M	Direct

Footnotes

On May 21, 2020, the Company completed the distribution to its stockholders of its shares of common stock in Evofem Biosciences, Inc., which resulted in a $0.58 reduction to the exercise price of the stock option at such time pursuant to the Company's wind-down retention plan. On October 1, 2020, the Company completed the distribution to its stockholders of its shares of common stock in LENSAR, Inc., which resulted in a $0.78 reduction to the exercise price of the stock option at such time pursuant to the Company's wind-down retention plan.